应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
TRVN Trevena, Inc.
交易中 11-22 09:36:00 EST 延时
资讯
新帖
简况
Trevena, Inc.盘中异动 早盘大幅下跌27.20%报1.82美元
市场透视 · 10-08
Trevena, Inc.盘中异动 早盘大幅下跌27.20%报1.82美元
Trevena, Inc.股价重挫47.67% 市值涨6.51万美元
市场透视 · 10-07
Trevena, Inc.股价重挫47.67% 市值涨6.51万美元
Trevena, Inc.盘中异动 早盘股价大涨5.06%
市场透视 · 10-04
Trevena, Inc.盘中异动 早盘股价大涨5.06%
Trevena, Inc.盘中异动 股价大涨6.11%
市场透视 · 10-03
Trevena, Inc.盘中异动 股价大涨6.11%
Trevena, Inc.盘中异动 大幅下跌6.09%报3.70美元
市场透视 · 10-02
Trevena, Inc.盘中异动 大幅下跌6.09%报3.70美元
Trevena, Inc.盘中异动 快速跳水5.78%
市场透视 · 10-01
Trevena, Inc.盘中异动 快速跳水5.78%
Trevena, Inc.盘中异动 股价大涨6.67%报4.16美元
市场透视 · 09-26
Trevena, Inc.盘中异动 股价大涨6.67%报4.16美元
Trevena, Inc.盘中异动 大幅上涨8.38%报4.01美元
市场透视 · 09-24
Trevena, Inc.盘中异动 大幅上涨8.38%报4.01美元
Trevena, Inc.盘中异动 早盘急速拉升7.23%
市场透视 · 09-23
Trevena, Inc.盘中异动 早盘急速拉升7.23%
Trevena, Inc.盘中异动 股价大跌5.96%
市场透视 · 09-21
Trevena, Inc.盘中异动 股价大跌5.96%
Trevena, Inc.股价拉升10.49% 市值涨48.35万美元
市场透视 · 09-19
Trevena, Inc.股价拉升10.49% 市值涨48.35万美元
Trevena, Inc.盘中异动 股价大跌6.97%
自选股智能写手 · 08-20
Trevena, Inc.盘中异动 股价大跌6.97%
Trevena, Inc.盘中异动 股价大涨5.63%
自选股智能写手 · 08-20
Trevena, Inc.盘中异动 股价大涨5.63%
Trevena, Inc.盘中异动 早盘快速拉升6.10%
自选股智能写手 · 08-16
Trevena, Inc.盘中异动 早盘快速拉升6.10%
Trevena, Inc.盘中异动 早盘股价大跌5.79%报3.58美元
自选股智能写手 · 08-15
Trevena, Inc.盘中异动 早盘股价大跌5.79%报3.58美元
Trevena, Inc.盘中异动 早盘急速下挫5.57%报4.24美元
自选股智能写手 · 08-14
Trevena, Inc.盘中异动 早盘急速下挫5.57%报4.24美元
Trevena, Inc.盘中异动 快速下挫8.87%
自选股智能写手 · 08-13
Trevena, Inc.盘中异动 快速下挫8.87%
Trevena Inc 报告截至 6 月的季度业绩 - 收益摘要
Reuters · 08-12
Trevena Inc 报告截至 6 月的季度业绩 - 收益摘要
Trevena Inc 报告截至 6 月的季度业绩 - 收益摘要
Reuters · 08-12
Trevena Inc 报告截至 6 月的季度业绩 - 收益摘要
Trevena, Inc.盘中异动 早盘股价大涨5.11%
自选股智能写手 · 08-12
Trevena, Inc.盘中异动 早盘股价大涨5.11%
公司概况
公司名称:
Trevena, Inc.
所属市场:
PINK
上市日期:
--
主营业务:
Trevena, Inc.是一家处于发展阶段的生物制药公司,以Parallax医疗公司之名在2007年11月9日成立,位于特拉华州。公司于2007年12月正式运作,2008年1月3日,更名为Trevena公司。公司是一家药物研发公司,专注于发现和研制针对G蛋白藕合受体的药品。公司有一项业务,总部位于在宾夕法尼亚普鲁士王市。公司利润来源于研究经费和与一家制药公司合作的收入。
发行价格:
--
{"stockData":{"symbol":"TRVN","market":"US","secType":"STK","nameCN":"Trevena, Inc.","latestPrice":1.75,"timestamp":1732286160000,"preClose":1.7567,"halted":0,"volume":264,"delay":15,"floatShares":846486,"shares":863788,"eps":-51.15894,"marketStatus":"交易中","marketStatusCode":2,"change":-0.0067,"latestTime":"11-22 09:36:00 EST 延时","open":1.7567,"high":1.76,"low":1.75,"amount":463.6399944,"amplitude":0.005692,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-51.15894,"exchange":"PINK","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1732309200000},"adr":0,"adjPreClose":1.7567,"volumeRatio":7.131775},"requestUrl":"/m/hq/s/TRVN/wiki","defaultTab":"wiki","newsList":[{"id":"2473751544","title":"Trevena, Inc.盘中异动 早盘大幅下跌27.20%报1.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473751544","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473751544?lang=zh_cn&edition=full","pubTime":"2024-10-08 21:46","pubTimestamp":1728395187,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日21时46分,Trevena, Inc.股票出现波动,股价快速跳水27.20%。截至发稿,该股报1.82美元/股,成交量4133股,换手率0.48%,振幅15.60%。Trevena, Inc.股票所在的生物技术行业中,整体涨幅为0.57%。Trevena, Inc.公司简介:Trevena Inc 是一家美国生物制药公司,专注于为受中枢神经系统或 CNS 疾病影响的患者开发和商业化新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410082146279f32455b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410082146279f32455b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRVN","BK4139"],"gpt_icon":0},{"id":"2473210349","title":"Trevena, Inc.股价重挫47.67% 市值涨6.51万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473210349","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473210349?lang=zh_cn&edition=full","pubTime":"2024-10-07 21:30","pubTimestamp":1728307808,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日21时30分,Trevena, Inc.股票出现波动,股价急速跳水47.67%。Trevena, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。其相关个股中,Scholar Rock Holding Corporation、Ibio, Inc.、Oculis Holding Ag C/Wts 06/03/2028 涨幅较大,Aditxt, Inc.、Phio Pharmaceuticals Corp.、Elevai Labs, Inc.较为活跃,换手率分别为488.72%、46.52%、9.16%,振幅较大的相关个股有Inventiva Sa、Actinium Pharmaceuticals, Inc. 、Ocugen, Inc.,振幅分别为4.81%、2.23%、1.98%。Trevena, Inc.公司简介:Trevena Inc 是一家美国生物制药公司,专注于为受中枢神经系统或 CNS 疾病影响的患者开发和商业化新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410072130089719e9ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410072130089719e9ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRVN","BK4139"],"gpt_icon":0},{"id":"2472957900","title":"Trevena, Inc.盘中异动 早盘股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472957900","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472957900?lang=zh_cn&edition=full","pubTime":"2024-10-04 21:44","pubTimestamp":1728049444,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日21时44分,Trevena, Inc.股票出现异动,股价急速拉升5.06%。Trevena, Inc.股票所在的生物技术行业中,整体涨幅为0.26%。其相关个股中,Aditxt, Inc.、Sagimet Biosciences Inc. - Series A、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大,Aditxt, Inc.、Theriva Biologics, Inc.、Elevai Labs, Inc.较为活跃,换手率分别为6629.30%、28.56%、24.45%,振幅较大的相关个股有Aditxt, Inc.、Sagimet Biosciences Inc. - Series A、Theriva Biologics, Inc.,振幅分别为46.39%、24.51%、11.73%。Trevena, Inc.公司简介:Trevena Inc 是一家美国生物制药公司,专注于为受中枢神经系统或 CNS 疾病影响的患者开发和商业化新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410042144049719e61b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410042144049719e61b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGMT","TRVN","BK4139"],"gpt_icon":0},{"id":"2472610527","title":"Trevena, Inc.盘中异动 股价大涨6.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472610527","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472610527?lang=zh_cn&edition=full","pubTime":"2024-10-03 23:21","pubTimestamp":1727968897,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日23时21分,Trevena, Inc.股票出现波动,股价急速上涨6.11%。Trevena, Inc.股票所在的生物技术行业中,整体跌幅为0.99%。其相关个股中,Elevai Labs, Inc.、Verrica制药、Theriva Biologics, Inc.涨幅较大,Theriva Biologics, Inc.、Aditxt, Inc.、Elevai Labs, Inc.较为活跃,换手率分别为4867.60%、1327.13%、861.76%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Elevai Labs, Inc.、Tc Biopharm Plc C/Wts 10/02/2028 ,振幅分别为142.28%、59.86%、43.48%。Trevena, Inc.公司简介:Trevena Inc 是一家美国生物制药公司,专注于为受中枢神经系统或 CNS 疾病影响的患者开发和商业化新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410032321379719e371&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410032321379719e371&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRVN","ELAB","BK4183","BK4139"],"gpt_icon":0},{"id":"2472526233","title":"Trevena, Inc.盘中异动 大幅下跌6.09%报3.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472526233","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472526233?lang=zh_cn&edition=full","pubTime":"2024-10-02 21:31","pubTimestamp":1727875879,"startTime":"0","endTime":"0","summary":"北京时间2024年10月02日21时31分,Trevena, Inc.股票出现异动,股价急速下挫6.09%。截至发稿,该股报3.70美元/股,成交量3273股,换手率0.38%,振幅0.00%。Trevena, Inc.股票所在的生物技术行业中,整体跌幅为0.87%。Trevena, Inc.公司简介:Trevena Inc 是一家美国生物制药公司,专注于为受中枢神经系统或 CNS 疾病影响的患者开发和商业化新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241002213119958bd59e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241002213119958bd59e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TRVN"],"gpt_icon":0},{"id":"2472304483","title":"Trevena, Inc.盘中异动 快速跳水5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472304483","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472304483?lang=zh_cn&edition=full","pubTime":"2024-10-01 02:25","pubTimestamp":1727720717,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日02时25分,Trevena, Inc.股票出现异动,股价大幅下跌5.78%。Trevena, Inc.股票所在的生物技术行业中,整体跌幅为0.59%。其相关个股中,Nkgen Biotech Inc C/Wts 31/05/2028、Capricor Therapeutics, Inc.、Kezar Life Sciences, Inc.涨幅较大,Aditxt, Inc.、Seelos Therapeutics, Inc.、Gri Bio, Inc.较为活跃,换手率分别为216.75%、60.79%、58.54%,振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Tc Biopharm Plc C/Wts 10/02/2028 、Surrozen Inc C/Wts 01/08/2031 ,振幅分别为87.30%、85.25%、48.53%。Trevena, Inc.公司简介:Trevena Inc 是一家美国生物制药公司,专注于为受中枢神经系统或 CNS 疾病影响的患者开发和商业化新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100102251798e39e71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100102251798e39e71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRVN","BK4139"],"gpt_icon":0},{"id":"2470723734","title":"Trevena, Inc.盘中异动 股价大涨6.67%报4.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470723734","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470723734?lang=zh_cn&edition=full","pubTime":"2024-09-26 21:43","pubTimestamp":1727358180,"startTime":"0","endTime":"0","summary":"北京时间2024年09月26日21时43分,Trevena, Inc.股票出现异动,股价快速拉升6.67%。截至发稿,该股报4.16美元/股,成交量937股,换手率0.11%,振幅0.00%。Trevena, Inc.股票所在的生物技术行业中,整体跌幅为0.21%。Trevena, Inc.公司简介:Trevena Inc 是一家美国生物制药公司,专注于为受中枢神经系统或 CNS 疾病影响的患者开发和商业化新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926214300957f7e8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926214300957f7e8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KTTA","TRVN"],"gpt_icon":0},{"id":"2469491124","title":"Trevena, Inc.盘中异动 大幅上涨8.38%报4.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469491124","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469491124?lang=zh_cn&edition=full","pubTime":"2024-09-24 21:31","pubTimestamp":1727184682,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日21时31分,Trevena, Inc.股票出现波动,股价大幅拉升8.38%。Trevena, Inc.股票所在的生物技术行业中,整体跌幅为0.34%。其相关个股中,Seelos Therapeutics, Inc.、Capricor Therapeutics, Inc.、Wave Life Sciences Ltd.涨幅较大,Seelos Therapeutics, Inc.、Silexion Therapeutics Corp、Elevai Labs, Inc.较为活跃,换手率分别为790.55%、143.21%、11.08%,振幅较大的相关个股有Seelos Therapeutics, Inc.、Eterna Therapeutics Inc.、Theriva Biologics, Inc.,振幅分别为22.63%、8.20%、7.02%。Trevena, Inc.公司简介:Trevena Inc 是一家美国生物制药公司,专注于为受中枢神经系统或 CNS 疾病影响的患者开发和商业化新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409242131229f13232f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409242131229f13232f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TRVN"],"gpt_icon":0},{"id":"2469500112","title":"Trevena, Inc.盘中异动 早盘急速拉升7.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469500112","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469500112?lang=zh_cn&edition=full","pubTime":"2024-09-23 21:39","pubTimestamp":1727098790,"startTime":"0","endTime":"0","summary":"北京时间2024年09月23日21时39分,Trevena, Inc.股票出现异动,股价大幅上涨7.23%。Trevena, Inc.股票所在的生物技术行业中,整体跌幅为0.51%。其相关个股中,Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Pharmacyte Biotech, Inc.、Cingulate Inc C/Wts 10/12/2026 涨幅较大,Galmed Pharmaceuticals Ltd.、Elevai Labs, Inc.、Scisparc Ltd.较为活跃,换手率分别为86.33%、25.26%、23.73%,振幅较大的相关个股有Pharmacyte Biotech, Inc.、天演药业、Galmed Pharmaceuticals Ltd.,振幅分别为23.46%、17.72%、16.05%。Trevena, Inc.公司简介:Trevena Inc 是一家美国生物制药公司,专注于为受中枢神经系统或 CNS 疾病影响的患者开发和商业化新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409232139519719c343&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409232139519719c343&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TRVN"],"gpt_icon":0},{"id":"2469676317","title":"Trevena, Inc.盘中异动 股价大跌5.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469676317","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469676317?lang=zh_cn&edition=full","pubTime":"2024-09-21 00:25","pubTimestamp":1726849535,"startTime":"0","endTime":"0","summary":"北京时间2024年09月21日00时25分,Trevena, Inc.股票出现异动,股价急速下挫5.96%。Trevena, Inc.股票所在的生物技术行业中,整体跌幅为1.62%。Trevena, Inc.公司简介:Trevena Inc 是一家美国生物制药公司,专注于为受中枢神经系统或 CNS 疾病影响的患者开发和商业化新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092100253698e384a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092100253698e384a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TRVN"],"gpt_icon":0},{"id":"2468773265","title":"Trevena, Inc.股价拉升10.49% 市值涨48.35万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468773265","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468773265?lang=zh_cn&edition=full","pubTime":"2024-09-19 21:33","pubTimestamp":1726752820,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日21时33分,Trevena, Inc.股票出现异动,股价大幅上涨10.49%。Trevena, Inc.股票所在的生物技术行业中,整体涨幅为0.90%。其相关个股中,Exicure, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Humacyte Inc C/Wts 27/08/2026 涨幅较大,Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Psyence Biomedical Ltd.较为活跃,换手率分别为1054.08%、376.90%、73.30%,振幅较大的相关个股有Exicure, Inc.、Portage Biotech Inc.、Galmed Pharmaceuticals Ltd.,振幅分别为54.59%、14.49%、13.77%。Trevena, Inc.公司简介:Trevena Inc 是一家美国生物制药公司,专注于为受中枢神经系统或 CNS 疾病影响的患者开发和商业化新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409192133409f07f1b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409192133409f07f1b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TRVN"],"gpt_icon":0},{"id":"2460004723","title":"Trevena, Inc.盘中异动 股价大跌6.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460004723","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460004723?lang=zh_cn&edition=full","pubTime":"2024-08-20 21:40","pubTimestamp":1724161208,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日21时40分,Trevena, Inc.股票出现波动,股价急速下挫6.97%。Trevena, Inc.股票所在的生物技术行业中,整体涨幅为0.23%。其相关个股中,Inmed Pharmaceuticals Inc.、泰坦制药、Apollomics Inc C/Wts 01/04/2028 涨幅较大,Inmed Pharmaceuticals Inc.、泰坦制药、Alzamend Neuro, Inc.较为活跃,换手率分别为1922.77%、425.18%、200.85%,振幅较大的相关个股有Inmed Pharmaceuticals Inc.、Biomotion Sciences C/Wts Exp 15/08/2029 、泰坦制药,振幅分别为127.84%、78.89%、49.00%。Trevena, Inc.公司简介:Trevena Inc 是一家美国生物制药公司,专注于为受中枢神经系统或 CNS 疾病影响的患者开发和商业化新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820214008a1d53b97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820214008a1d53b97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRVN","BK4139"],"gpt_icon":0},{"id":"2460705483","title":"Trevena, Inc.盘中异动 股价大涨5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460705483","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460705483?lang=zh_cn&edition=full","pubTime":"2024-08-20 00:29","pubTimestamp":1724084973,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日00时29分,Trevena, Inc.股票出现波动,股价快速拉升5.63%。Trevena, Inc.股票所在的生物技术行业中,整体涨幅为1.35%。其相关个股中,Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Revelation Biosciences Inc C/Wts 10/01/2027 涨幅较大,Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Tonix Pharmaceuticals Holding Corp.较为活跃,换手率分别为7358.08%、3407.58%、1085.75%,振幅较大的相关个股有Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Revelation Biosciences Inc C/Wts 10/01/2027 ,振幅分别为405.90%、220.18%、196.04%。Trevena, Inc.公司简介:Trevena Inc 是一家美国生物制药公司,专注于为受中枢神经系统或 CNS 疾病影响的患者开发和商业化新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820002933971992d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820002933971992d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRVN","ALZN","BK4139","BK4539"],"gpt_icon":0},{"id":"2459212989","title":"Trevena, Inc.盘中异动 早盘快速拉升6.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459212989","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459212989?lang=zh_cn&edition=full","pubTime":"2024-08-16 21:34","pubTimestamp":1723815244,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日21时34分,Trevena, Inc.股票出现异动,股价大幅上涨6.10%。Trevena, Inc.股票所在的生物技术行业中,整体跌幅为0.25%。其相关个股中,Cingulate Inc.、Cingulate Inc C/Wts 10/12/2026 、Seelos Therapeutics, Inc.涨幅较大,Cingulate Inc.、Seelos Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃,换手率分别为2777.93%、1084.38%、120.09%,振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Cingulate Inc.、Tonix Pharmaceuticals Holding Corp.,振幅分别为100.53%、31.46%、15.17%。Trevena, Inc.公司简介:Trevena Inc 是一家美国生物制药公司,专注于为受中枢神经系统或 CNS 疾病影响的患者开发和商业化新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816213404ab5e152a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816213404ab5e152a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRVN","BK4007","BK4139"],"gpt_icon":1},{"id":"2459479717","title":"Trevena, Inc.盘中异动 早盘股价大跌5.79%报3.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459479717","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459479717?lang=zh_cn&edition=full","pubTime":"2024-08-15 23:08","pubTimestamp":1723734519,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日23时08分,Trevena, Inc.股票出现异动,股价快速下跌5.79%。截至发稿,该股报3.58美元/股,成交量7423股,换手率0.87%,振幅4.74%。Trevena, Inc.股票所在的生物技术行业中,整体涨幅为0.91%。Trevena, Inc.公司简介:Trevena Inc 是一家美国生物制药公司,专注于为受中枢神经系统或 CNS 疾病影响的患者开发和商业化新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815230839a1d474a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815230839a1d474a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TRVN"],"gpt_icon":0},{"id":"2459341174","title":"Trevena, Inc.盘中异动 早盘急速下挫5.57%报4.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459341174","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459341174?lang=zh_cn&edition=full","pubTime":"2024-08-14 21:32","pubTimestamp":1723642350,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日21时32分,Trevena, Inc.股票出现异动,股价大幅下挫5.57%。截至发稿,该股报4.24美元/股,成交量1756股,换手率0.21%,振幅1.34%。Trevena, Inc.股票所在的生物技术行业中,整体跌幅为0.34%。Trevena, Inc.公司简介:Trevena Inc 是一家美国生物制药公司,专注于为受中枢神经系统或 CNS 疾病影响的患者开发和商业化新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408142132309f2ac186&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408142132309f2ac186&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRVN","BK4139"],"gpt_icon":0},{"id":"2459060779","title":"Trevena, Inc.盘中异动 快速下挫8.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459060779","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459060779?lang=zh_cn&edition=full","pubTime":"2024-08-13 21:32","pubTimestamp":1723555972,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日21时32分,Trevena, Inc.股票出现异动,股价快速跳水8.87%。Trevena, Inc.股票所在的生物技术行业中,整体涨幅为0.34%。其相关个股中,Cardio Diagnostics Holdings Inc C/Wts To Pur Com、冠科美博、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大,Genprex, Inc.、冠科美博、Psyence Biomedical Ltd.较为活跃,换手率分别为107.37%、68.09%、18.36%,振幅较大的相关个股有冠科美博、Jaguar Health, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026,振幅分别为26.28%、15.12%、10.94%。Trevena, Inc.公司简介:Trevena Inc 是一家美国生物制药公司,专注于为受中枢神经系统或 CNS 疾病影响的患者开发和商业化新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408132132529f278e22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408132132529f278e22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRVN","BK4139"],"gpt_icon":0},{"id":"2458982776","title":"Trevena Inc 报告截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2458982776","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458982776?lang=zh_cn&edition=full","pubTime":"2024-08-12 23:10","pubTimestamp":1723475410,"startTime":"0","endTime":"0","summary":" * Trevena Inc 报告,截至6月底的季度调整后每股亏损23美分,高于去年同期的每股-69美分。两位分析师对该季度的平均预期是每股亏损 40 美分。华尔街预期为每股-44美分至-37美分。* Trevena Inc 公布的本季度每股收益为亏损 23 美分。* 该公司当季亏损 489 万美元。* Trevena Inc 的股价本季度下跌了 8.4%,今年迄今为止下跌了 72.3%。8月12日 - 预测变化 * 在过去三个月中,分析师的平均盈利预期上升了约 3.6%。华尔街对 Trevena Inc 的 12 个月目标价中位数为 4.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TRVN"],"gpt_icon":0},{"id":"2458982772","title":"Trevena Inc 报告截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2458982772","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458982772?lang=zh_cn&edition=full","pubTime":"2024-08-12 23:10","pubTimestamp":1723475410,"startTime":"0","endTime":"0","summary":" * Trevena Inc 报告,截至6月底的季度调整后每股亏损23美分,高于去年同期的每股-69美分。两位分析师对该季度的平均预期是每股亏损 40 美分。华尔街预期为每股-44美分至-37美分。* Trevena Inc 公布的本季度每股收益为亏损 23 美分。* 该公司当季亏损 489 万美元。* Trevena Inc 的股价本季度下跌了 8.4%,今年迄今为止下跌了 72.3%。8月12日 - 预测变化 * 在过去三个月中,分析师的平均盈利预期上升了约 3.6%。华尔街对 Trevena Inc 的 12 个月目标价中位数为 4.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Trevena Inc 报告截至 6 月的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRVN","BK4139"],"gpt_icon":0},{"id":"2458498523","title":"Trevena, Inc.盘中异动 早盘股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458498523","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458498523?lang=zh_cn&edition=full","pubTime":"2024-08-12 21:36","pubTimestamp":1723469763,"startTime":"0","endTime":"0","summary":"北京时间2024年08月12日21时36分,Trevena, Inc.股票出现波动,股价急速上涨5.11%。Trevena, Inc.股票所在的生物技术行业中,整体跌幅为0.55%。其相关个股中,Revance Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Oragenics Inc.涨幅较大,60 Degrees Pharmaceuticals, Inc.、Revance Therapeutics, Inc.、Oragenics Inc.较为活跃,换手率分别为50.64%、21.90%、21.48%,振幅较大的相关个股有Oragenics Inc.、Sangamo Therapeutics, Inc.、60 Degrees Pharmaceuticals, Inc.,振幅分别为30.36%、22.55%、21.44%。Trevena, Inc.公司简介:Trevena Inc 是一家美国生物制药公司,专注于为受中枢神经系统或 CNS 疾病影响的患者开发和商业化新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081221360394200042&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081221360394200042&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRVN","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.trevenainc.com","description":"Trevena, Inc.是一家处于发展阶段的生物制药公司,以Parallax医疗公司之名在2007年11月9日成立,位于特拉华州。公司于2007年12月正式运作,2008年1月3日,更名为Trevena公司。公司是一家药物研发公司,专注于发现和研制针对G蛋白藕合受体的药品。公司有一项业务,总部位于在宾夕法尼亚普鲁士王市。公司利润来源于研究经费和与一家制药公司合作的收入。","exchange":"PINK","name":"Trevena, Inc.","nameEN":"Trevena, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Trevena, Inc.(TRVN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Trevena, Inc.(TRVN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Trevena, Inc.,TRVN,Trevena, Inc.股票,Trevena, Inc.股票老虎,Trevena, Inc.股票老虎国际,Trevena, Inc.行情,Trevena, Inc.股票行情,Trevena, Inc.股价,Trevena, Inc.股市,Trevena, Inc.股票价格,Trevena, Inc.股票交易,Trevena, Inc.股票购买,Trevena, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Trevena, Inc.(TRVN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Trevena, Inc.(TRVN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}